Skip to content

Kepler View

We believe MNP’s (Martin Currie Global Portfolio Trust's) significant periods of strong performance have highlighted the alpha-generating potential that Zehrid’s high-conviction, quality growth-focussed strategy can provide. We believe the strategy is likely to suit longer-term investors looking to gain exposure to a selection of core secular growth themes that seem likely to drive global equities for many years to come. That said, a strong stomach may be required for periods of volatility and underperformance during value-driven market environments.

We believe MNP’s (Martin Currie Global Portfolio Trust's) significant periods of strong performance have highlighted the alpha-generating potential that Zehrid’s high-conviction, quality growth-focused strategy can provide.

The team has a meticulous approach to fundamental equity research and the systematic integration of ESG. In our view, the established, market-leading businesses within the Portfolio, combined with their exposure to key thematic growth drivers, should be better positioned in a lower growth, tighter macroeconomic environment.

As we move closer to the end of the interest rate-hiking cycle, we think this could start to provide support to quality-growth stocks. At the time of writing, the Discount of 2% seems attractive to us, too, as the zero-discount policy has tended to keep the shares trading closer to NAV (Net Asset Value). While substantial buybacks have not been enough to keep the shares trading at par this year, we think this is likely a temporary phenomenon thanks to the extremely high levels of risk aversion in markets.

Download full report

This research note has been commissioned by Martin Currie Global Portfolio Trust from Kepler Partners. The research note does not constitute independent research for the purpose of legal and regulatory requirements and is therefore not subject to the regulatory protections afforded to independent research. In particular, the research note is not subject to any prohibition on dealing and both Kepler Partners and Martin Currie/Franklin Templeton, and their respective staff, may have dealt in the securities discussed in the research note.